senktide has been researched along with norbinaltorphimine in 5 studies
| Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (norbinaltorphimine) | Trials (norbinaltorphimine) | Recent Studies (post-2010) (norbinaltorphimine) |
|---|---|---|---|---|---|
| 292 | 1 | 50 | 918 | 0 | 205 |
| Protein | Taxonomy | senktide (IC50) | norbinaltorphimine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0104 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0029 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.212 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.024 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameyama, T; Shinkai, N; Ukai, M | 1 |
| Blomenröhr, M; García-Galiano, D; Gaytan, F; Krajnc-Franken, MA; Leon, S; Manfredi-Lozano, M; Navarro, VM; Pinilla, L; Romero-Ruiz, A; Tena-Sempere, M; van Ingen Schenau, D; van Noort, PI | 1 |
| Elsamani, L; Grachev, P; Hu, MH; Li, XF; Lightman, SL; Lin, YS; Millar, RP; O'Byrne, KT; Paterson, SJ | 1 |
| Deura, C; Fujii, N; Iwase, A; Kikkawa, F; Maeda, K; Minabe, S; Nakahara, T; Nakamura, S; Noguchi, T; Oishi, S; Tsukamura, H; Uenoyama, Y; Watanabe, Y | 1 |
| Irahara, M; Iwasa, T; Kato, T; Kuwahara, A; Matsui, S; Matsuzaki, T; Mayila, Y; Munkhzaya, M; Tokui, T; Tungalagsuvd, A; Yanagihara, R; Yano, K | 1 |
5 other study(ies) available for senktide and norbinaltorphimine
| Article | Year |
|---|---|
Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice.
Topics: Animals; Male; Mice; Muscarinic Antagonists; Naloxone; Naltrexone; Narcotic Antagonists; Neurokinin A; Peptide Fragments; Psychomotor Performance; Scopolamine; Substance P; Tachykinins | 1998 |
Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice.
Topics: Adamantane; Animals; Dipeptides; Follicle Stimulating Hormone; Galanin-Like Peptide; Glutamic Acid; Gonadotropin-Releasing Hormone; Gonadotropins; Hypogonadism; Kisspeptins; Luteinizing Hormone; Male; Mice; Mice, Knockout; Models, Neurological; Naltrexone; Neurokinin B; Peptide Fragments; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide; Signal Transduction; Substance P; Testosterone | 2012 |
GPR54-dependent stimulation of luteinizing hormone secretion by neurokinin B in prepubertal rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antihypertensive Agents; Bodily Secretions; Female; Kisspeptins; Luteinizing Hormone; Male; Naltrexone; Narcotic Antagonists; Neurokinin B; Peptide Fragments; Radioimmunoassay; Rats; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, Tachykinin; Substance P | 2012 |
Chronic peripheral administration of kappa-opioid receptor antagonist advances puberty onset associated with acceleration of pulsatile luteinizing hormone secretion in female rats.
Topics: Animals; Drug Implants; Dynorphins; Female; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Nerve Tissue Proteins; Neurokinin B; Neurons; Ovary; Peptide Fragments; Puberty, Precocious; Random Allocation; Rats; Rats, Wistar; Receptors, Neurokinin-3; Receptors, Opioid, kappa; Sexual Maturation; Signal Transduction; Substance P; Weaning | 2013 |
Neurokinin B receptor agonist and Dynorphin receptor antagonist stimulated luteinizing hormone secretion in fasted male rodents.
Topics: Animals; Fasting; Luteinizing Hormone; Male; Naltrexone; Narcotic Antagonists; Neurokinin B; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Receptors, Opioid; Signal Transduction; Substance P | 2018 |